MedPath

The combination therapy of prednisolone and cyclosporine for initial onset of Vogt-Koyanagi-Harada disease.

Not Applicable
Recruiting
Conditions
Vogt-Koyanagi-Harada disease
Registration Number
JPRN-UMIN000014041
Lead Sponsor
Yamaguchi University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria

Not provided

Exclusion Criteria

1.Renal dysfunction 2.Immunosuppressant treatment including steroid 3.Immunocompromised condition 4.Females who are pregnant or lactating patients or who are suspicious of pregnant 5.Malignant neoplasm 6.Ontraocular surgery (except for cataract surgery) or glaucoma surgery previously,or speculate to be required in the periods of this study 7.Investigator declare a subject ineligible for any sound reasons

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Proportion of subjects showing recurrences of uveitis with VKH disease
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath